CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy

被引：7

作者：

Ramachandran, Raja ^{[1
]}

Yadav, Ashok K. ^{[1
]}

Kumar, Vinod ^{[1
]}

Gupta, Krishan L. ^{[1
]}

Kohli, Harbir S. ^{[1
]}

机构：

[1] PGIMER, Dept Nephrol, Chandigarh, India

来源：

KIDNEY INTERNATIONAL REPORTS | 2017年 / 2卷 / 01期

关键词：

D O I：

10.1016/j.ekir.2016.08.019

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：89 / 90

页数：2

共 6 条

[1]

[Anonymous], 2012, Kidney Int Suppl (2011), V2, P186

[2] Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy [J].

Cravedi, Paolo ;

Ruggenenti, Piero ;

Sghirlanzoni, Maria Chiara ;

Remuzzi, Giuseppe .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (05) :932-937

[3]

Dahan K., 2016, J Am Soc Nephrol

[4] Evaluation of Rituximab Dosage for ABO-Incompatible Living-donor Kidney Transplantation [J].

Nakao, T. ;

Ushigome, H. ;

Kawai, K. ;

Nakamura, T. ;

Harada, S. ;

Koshino, K. ;

Suzuki, T. ;

Ito, T. ;

Nobori, S. ;

Yoshimura, N. .

TRANSPLANTATION PROCEEDINGS, 2015, 47 (03) :644-648

[5] PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians [J].

Ramachandran, Raja ;

Kumar, Vinod ;

Kumar, Ashwani ;

Yadav, Ashok Kumar ;

Nada, Ritambhra ;

Kumar, Harsha ;

Kumar, Vivek ;

Rathi, Manish ;

Kohli, Harbir Singh ;

Gupta, Krishan Lal ;

Sakhuja, Vinay ;

Jha, Vivekanand .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (09) :1486-1493

[6] Rituximab in Idiopathic Membranous Nephropathy [J].

Ruggenenti, Piero ;

Cravedi, Paolo ;

Chianca, Antonietta ;

Perna, Annalisa ;

Ruggiero, Barbara ;

Gaspari, Flavio ;

Rambaldi, Alessandro ;

Marasa, Maddalena ;

Remuzzi, Giuseppe .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (08) :1416-1425

← 1 →